Vivos Therapeutics, Inc. Increase (Decrease) in Other Operating Liabilities
Vivos Therapeutics, Inc. (VVOS) reported Increase (Decrease) in Other Operating Liabilities of -$1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-14
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$386.00K, a 255.65% decline year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $385.00K, a 3.27% decline year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$521.00K.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $358.00K, a 35700.00% increase year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $483.00K.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $41.00K, a 71.53% decline from fiscal 2022.
- Vivos Therapeutics, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $144.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.00K 10-Q · filed 2026-08-14 | -$522.00K derived: sum of 3 quarters · filed 2026-08-14 | -$164.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $385.00K 10-Q · filed 2026-05-20 | -$136.00K derived: sum of 2 quarters · filed 2026-05-20 | $222.00K derived: sum of 3 quarters · filed 2026-05-20 | $470.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$521.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$163.00K derived: sum of 2 quarters · filed 2026-04-15 | $85.00K derived: sum of 3 quarters · filed 2026-08-14 | $483.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $606.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.00M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $646.00K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $398.00K 10-Q · filed 2026-05-20 | |||
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$22.00K derived: sum of 2 quarters · filed 2025-11-19 | -$1.00K 10-Q · filed 2025-11-19 | -$54.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$2.00K 10-Q · filed 2025-08-19 | -$55.00K derived: sum of 3 quarters · filed 2025-08-19 | $37.00K derived: sum of 4 quarters · filed 2025-08-19 |
| 2024-03-31 | $21.00K 10-Q · filed 2025-05-15 | -$32.00K derived: sum of 2 quarters · filed 2025-05-15 | $60.00K derived: sum of 3 quarters · filed 2025-05-15 | $93.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $39.00K derived: sum of 2 quarters · filed 2025-03-31 | $72.00K derived: sum of 3 quarters · filed 2025-03-31 | $41.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $125.00K derived: sum of 2 quarters · filed 2024-11-14 | $94.00K 10-Q · filed 2024-11-14 | -$23.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.00K 10-Q · filed 2024-08-14 | -$115.00K derived: sum of 3 quarters · filed 2024-08-14 | -$84.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$31.00K 10-Q · filed 2024-05-14 | -$148.00K derived: sum of 2 quarters · filed 2024-07-30 | -$117.00K derived: sum of 3 quarters · filed 2024-07-30 | |
| 2022-12-31 | -$117.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | -$86.00K derived: sum of 2 quarters · filed 2024-07-30 | $144.00K 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $261.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $230.00K 10-Q · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |